New Australian Study Shows Teen E-Cigarette Use on the Rise

Sep.28.2022
New Australian Study Shows Teen E-Cigarette Use on the Rise
Australian study reveals vaping is easy for teens to access, with taste being the primary factor in product selection.

A recent study, published in the Australian and New Zealand Journal of Public Health, has shown that nearly 80% of teenagers who use e-cigarettes find it "very easy" to obtain them from multiple illegal sources, while taste is the main factor driving product selection. This is the first study of its kind in Australia.


The University of Sydney's Centre and the University of Sydney are conducting a leading research project, supported by the Minderoo Foundation, aimed at investigating the experiences and opinions of teenagers towards e-cigarettes in Australia.


A survey has found that 70% of teenage e-cigarette users obtain the products for free from individuals, while 30% purchase them themselves from "friends" or commercial retail stores such as convenience stores and tobacco shops. Teenagers also reported purchasing e-cigarettes through social media, e-cigarette stores, and websites.


The committee stated that the investigation results indicate that the government's control measures aimed at protecting young people from the harms of e-cigarettes have failed.


Regardless of how teenagers obtain electronic cigarettes, they are all illegal, and yet it is happening right under the noses of federal and state authorities," Ms. Desai said. "All Australian governments have stated that they are committed to ensuring that only smokers attempting to quit with a prescription can use e-cigarettes. However, a crisis of teenage e-cigarette use is looming.


The widespread illicit use of e-cigarettes among young people, coupled with the import, retail and wholesale sales of these products, has escalated from an urgent concern to a crisis. According to Becky Freeman, the lead researcher and associate professor at the University of Sydney, the findings reflect how e-cigarettes are marketed and promoted to the youth market.


According to the survey, 32% of adolescents surveyed have tried electronic cigarettes by taking at least a few puffs. Of those who have tried e-cigarettes, more than half had never smoked tobacco before," said Professor Freeman.


Ruby Ellis, a 17-year-old teenager from New South Wales, has been vaping for three years. She acknowledges that she knew it was addictive when she first started, but didn't fully grasp the intensity of addiction until she succumbed to it herself. "Prior to being addicted, you don't really understand the full implications of addiction and how it impacts you," she said.


Ruby is just one of many people in New South Wales who currently vape and describe it as being available anytime, anywhere. "It's always around, whether someone is having a cup of coffee, studying, or even taking a break in the restroom.


Ms. Dessaix stated that urgent action is needed to effectively enforce regulations and protect all young Australians from the harm of e-cigarettes.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not reflect the views of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity or accuracy of the article's content. The translation of this article is solely intended for industry exchange and research.


Due to limitations in translation ability, the translated article may not necessarily convey the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS adheres completely to the positions and statements of the Chinese government on all matters related to domestic issues, as well as those involving Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris said it is accelerating its transition toward smoke-free products in Spain and claimed that the related economic impact now exceeds EUR 3.3 billion. Philip Morris also said that more than 90% of nicotine consumption in Spain still comes from conventional cigarettes, leaving room for growth in smoke-free categories, while regulation and taxation remain major obstacles in its view.
Apr.21 by 2FIRSTS.ai
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Product | Geek Bar BURJ 80K Extends High-Puff Competition Into Hookah-Style DTL Use
Product | Geek Bar BURJ 80K Extends High-Puff Competition Into Hookah-Style DTL Use
2Firsts has noted that Geek Bar has added BURJ to its official product portfolio under the E-HOOKAH category. Public information shows that BURJ 80K is a hookah-style disposable vape featuring a 25ml e-liquid capacity, a 1500mAh battery, 0.4Ω dual coils and three operating modes: ECO, Regular and Pulse. According to publicly available product information, the device is rated for up to 80,000 puffs in ECO mode and uses a nicotine strength of 0.5% (5mg/ml).
Market
May.29
VEEV Arrives in South Korea, Completing PMI’s IQOS-ZYN-VEEV Portfolio
VEEV Arrives in South Korea, Completing PMI’s IQOS-ZYN-VEEV Portfolio
Philip Morris Korea has officially launched its VEEV e-vapor brand in South Korea, introducing both the VEEV inPRIME device and VEEBI inPRIME pods. The launch further expands PMI’s smoke-free portfolio in Korea, alongside its IQOS heated tobacco products and ZYN nicotine pouches.
Jun.16